Evaluate Immunogenicity, Safety, & Reactogenicity of Rotavac® in Healthy

See also
Status	Clinical Trial	Phase
Completed	`NCT02538211` - The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses	N/A
Completed	`NCT02220439` - Does the Fecal Microbiome Influence Rotarix Immunogenicity	N/A
Withdrawn	`NCT00757926` - Safety and Immunogenicity Study of the Recombinant Human Bovine Reassortant Rotavirus Vaccine in Healthy Indian Infants	Phase 1/Phase 2
Not yet recruiting	`NCT00484952` - Surveillance of Hospitalizations Due to Rotavirus Infections Among Children From Israel	N/A
Completed	`NCT00092443` - Dose Confirmation Efficacy Study (V260-007)	Phase 3
Terminated	`NCT01357174` - ROTATEQ™ Post-Marketing Surveillance in the Philippines	N/A
Recruiting	`NCT01363726` - Surveillance of Rotavirus Gastroenteritis in Children <5 Years	N/A
Completed	`NCT00130832` - Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED)	Phase 3
Recruiting	`NCT06080906` - Phase II Clinical Trial of the Inactivated Rotavirus Vaccine	Phase 2
Recruiting	`NCT03313128` - SaniVac Trial - Sanitation and Oral Rotavirus Vaccine Performance
Completed	`NCT02542462` - Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study	Phase 4
Completed	`NCT00346892` - To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV	Phase 2
Not yet recruiting	`NCT05212935` - A Surveillance Study on Timing and Coverage Of Rotavirus and MenB Vaccine Co-administration in Campania Region, Italy
Completed	`NCT00092456` - Consistency Lots Vaccine Study (V260-009)	Phase 3
Completed	`NCT00981669` - Rotavirus Vaccine Produced by Butantan Institute	Phase 1
Completed	`NCT05037435` - Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years.	Phase 3
Completed	`NCT03483116` - A Phase II Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine	Phase 2
Completed	`NCT03870061` - Evaluation of an Infant Immunization Encouragement Program in Nigeria	N/A
Active, not recruiting	`NCT05621655` - Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers	Phase 2
Completed	`NCT00280111` - Safety and Immunogenicity Study of Live Attenuated Indian Rotavirus Vaccine Candidate Strains 116E and I321 in Infants	Phase 1

NCT number	NCT03367559
Study type	Interventional
Source	Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products
Contact
Status	Enrolling by invitation
Phase	Phase 3
Start date	February 8, 2018
Completion date	May 2019

Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac® in Healthy Infants Aged Between 6-8 Weeks in Vietnam

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms